ArticleBriefings in bioinformatics2026
Cell type-specific dissection of cell death programs during ovarian aging.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The accurate deconvolution of bulk transcriptomes typically confounds stable physical cell identities with dynamic physiological states, limiting our understanding of complex microenvironmental processes such as ovarian aging. To overcome this, we present DeepMCD, an end-to-end multi-task deep learning framework designed to simultaneously deconvolve cell-type proportions and programmed cell death (PCD) compositional fractions from standard bulk RNA-seq data. By mapping high-dimensional expression profiles into a shared, tokenized latent space, DeepMCD employs a Transformer-based cross-task attention mechanism to explicitly leverage cellular morphological context for calibrating PCD predictions. Concurrently, an adaptive uncertainty-weighting loss ensures balanced optimization, effectively mitigating negative transfer. Extensive benchmarking demonstrates that DeepMCD significantly outperforms state-of-the-art single-task algorithms. Through rigorous ablation and interpretability analyses, we computationally substantiate the biological premise that functional death states are heavily reliant on specific cell-type contexts. Applying DeepMCD to real-world mouse ovarian aging cohorts, we reconstructed a cell-type-specific PCD landscape, bypassing the need for costly single-cell sequencing. Specifically, we identified an age-associated increase in inflammatory and lytic death modalities, together with a strong association between macrophage enrichment and pyroptosis during ovarian aging. Crucially, the DeepMCD-derived PCD fractions exhibit profound divergent correlations with core ovarian fibrosis-related genes. These computationally extracted signatures may serve as cost-effective candidate digital biomarkers for evaluating ovarian fibrosis and reproductive senescence. Ultimately, DeepMCD provides a highly interpretable, robust, and scalable computational tool for bulk RNA-seq data decoding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.